IO Biotech Company
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Industry:
Peptides and Proteins
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Investors Number:
16
Headquarters:
Copenhagen, Hovedstaden, Denmark
Employee Number:
11-50
Total Funding:
175012360
Founded Date:
2014-12-23
Last Funding Type:
Series C
Last Funding Date:
2021-10-07